These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 15190072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
    Chernock RD, Cherla RP, Ganju RK.
    Blood; 2001 Feb 01; 97(3):608-15. PubMed ID: 11157475
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
    Qu X, Sada K, Kyo S, Maeno K, Miah SM, Yamamura H.
    Blood; 2004 Mar 01; 103(5):1779-86. PubMed ID: 14604964
    [Abstract] [Full Text] [Related]

  • 10. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE, Paik PK, Samelson LE.
    Mol Cell Biol; 1999 Oct 01; 19(10):6652-64. PubMed ID: 10490604
    [Abstract] [Full Text] [Related]

  • 11. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM, Corey SJ.
    Oncogene; 1997 May 01; 14(17):2019-24. PubMed ID: 9160881
    [Abstract] [Full Text] [Related]

  • 12. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
    Hall AB, Jura N, DaSilva J, Jang YJ, Gong D, Bar-Sagi D.
    Curr Biol; 2003 Feb 18; 13(4):308-14. PubMed ID: 12593796
    [Abstract] [Full Text] [Related]

  • 13. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
    Goh EL, Zhu T, Leong WY, Lobie PE.
    Endocrinology; 2002 Sep 18; 143(9):3590-603. PubMed ID: 12193575
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.
    Mason JM, Morrison DJ, Bassit B, Dimri M, Band H, Licht JD, Gross I.
    Mol Biol Cell; 2004 May 18; 15(5):2176-88. PubMed ID: 15004239
    [Abstract] [Full Text] [Related]

  • 15. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
    Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C.
    J Cell Biol; 2005 Mar 28; 168(7):1065-76. PubMed ID: 15781477
    [Abstract] [Full Text] [Related]

  • 16. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A, Bellosta P, Sahni M, Basilico C.
    J Cell Biol; 2000 Jun 12; 149(6):1297-308. PubMed ID: 10851026
    [Abstract] [Full Text] [Related]

  • 17. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK, Anderson SM.
    J Biol Chem; 2004 Jul 02; 279(27):28017-27. PubMed ID: 15117950
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase.
    Anderson SM, Burton EA, Koch BL.
    J Biol Chem; 1997 Jan 10; 272(2):739-45. PubMed ID: 8995358
    [Abstract] [Full Text] [Related]

  • 19. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
    Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y.
    Curr Biol; 2003 Feb 18; 13(4):297-307. PubMed ID: 12593795
    [Abstract] [Full Text] [Related]

  • 20. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
    Gioia R, Trégoat C, Dumas PY, Lagarde V, Prouzet-Mauléon V, Desplat V, Sirvent A, Praloran V, Lippert E, Villacreces A, Leconet W, Robert B, Vigon I, Roche S, Mahon FX, Pasquet JM.
    J Pathol; 2015 Sep 18; 237(1):14-24. PubMed ID: 25965880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.